Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Daily News

Unplanned PCI Rare After TAVI, but Operators Get Good Results

Michael O'Riordan

January 18, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Advertisement

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Unplanned PCI Rare After TAVI, but Operators Get Good Results

TCTMD’s Top 10 Most Popular Stories for October 2020

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

TCTMD’s Top 10 Most Popular Stories for July 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content